Benzyl-methyl-Fluoro-bromophenyl-1,4-dihydropyrimidine-carboxylate-Cpd9a

IC50 0.626 +/- 0.151

General

Type : Pyrimidine

Chemical_Nomenclature : Benzyl 6 methyl-(2-Fluoro-4-bromophenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate

Canonical SMILES : C1=CC=C(C=C1)COC(C2=C(NC(NC2C3=CC=C(C(=C3)F)Br)=O)C)=O

InChI : InChI=1S\/C19H16BrFN2O3\/c1-11-16(18(24)26-10-12-5-3-2-4-6-12)17(23-19(25)22-11)13-7-8-14(20)15(21)9-13\/h2-9,17H,10H2,1H3,(H2,22,23,25)

InChIKey : ATWRJYQGDVABIG-UHFFFAOYSA-N

Other name(s) : benzyl 2-Fluoro4-bromophenyl)-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate  ||  Compound 9a


MW : 419.249

Formula : C19H16BrFN2O3

CAS_number :

PubChem :

UniChem : ATWRJYQGDVABIG-UHFFFAOYSA-N

Target

References (1)

Title : Dihydropyrimidines Emerge as Promising Dual-Acting Inhibitors Targeting Acetylcholinesterase and Monoamine Oxidases for Alzheimer's and Other Neurological Disorders - Khan_2025_ChemistrySelect_10_e202405063
Author(s) : Khan MS , Islam T , Farooq MU , al-Arifa N , Jalil S , Ali Khan IA , Hameed A , Asari A , Ur Rehman A , Iqbal J , Al-Rashida M
Ref : ChemistrySelect , 10 :e202405063 , 2025
Abstract :
PubMedSearch : Khan_2025_ChemistrySelect_10_e202405063
PubMedID: